DH
Definitive Healthcare Corp.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- A Jun 29 B of A Securities downgrades
- R Aug 10 Definitive Healthcare reported Q2 2026 revenue of $55.2M, a 9% YoY d…
- R Aug 15 A mixed institutional cluster in DH for Q2 2026 shows 5 small buyers…
- E Sep 2 M&A: Special Committee of Definitive Healthcare Board Confirms…
- R Sep 2 Definitive Healthcare Corp. (DH) disclosed that its Special Committe…
- R Sep 2 Definitive Healthcare's Special Committee announced receipt of a non…
- R Sep 9 Major TRA holders (Advent International, Spectrum Equity, 22C Capita…
- R Oct 2 Advent International filed Amendment No. 1 to its Schedule 13D, disc…
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsMIXED
Q2 2026: 13 added (0 new), 19 trimmed or exited.
- AnalystsBEARISH
1 of 15 rate it Buy or better. Median target $1.50 (+39%).
- TrendUPTREND
14% above its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| WELLS FARGO & COMPANY/MN | NEAR_EXIT | — |
| BlackRock, Inc. | TRIM | $1.2M |
| GEODE CAPITAL MANAGEMENT, LLC | TRIM | $457.9K |
| JACOBS LEVY EQUITY MANAGEMENT, INC | ADD | $392.8K |
| Squarepoint Ops LLC | ADD | $292.1K |
| MILLENNIUM MANAGEMENT LLC | TRIM | $229.2K |
| MORGAN STANLEY | TRIM | $211.2K |
| STATE STREET CORP | TRIM | $200.8K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
15 analystsPrice is inside the target range. Median implies +39%.Targets as of Oct 27, 2026.
| Date | Firm | Rating |
|---|---|---|
| Aug 11, 2026 | Morgan Stanley MAINTAIN | Equal-Weight |
| Jun 29, 2026 | B of A Securities DOWNGRADE | Underperform |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Oct 1, 2026 | Heller Casey Chief Financial Officer | TAX W/H | $11.7K |
| Oct 1, 2026 | Paris Jonathan Chief Legal Officer | TAX W/H | $7.2K |
| Sep 1, 2026 | Heller Casey Chief Financial Officer | TAX W/H | $37.1K |
| Aug 1, 2026 | Heller Casey Chief Financial Officer | TAX W/H | $1.3K |
| Aug 1, 2026 | Krantz Jason Ronald Director | TAX W/H | $8.3K |
| Jul 1, 2026 | Coop Kevin Chief Executive Officer | TAX W/H | $30.1K |
| Jul 1, 2026 | Paris Jonathan Chief Legal Officer | TAX W/H | $24.5K |
| Jun 4, 2026 | Stephenson Scott G Director | AWARD | 189,190 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | $0.04 | $0.03–$0.05 | -10.4% | $55.6M |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 15, 2026SecBot reports
11 filings · 1 press release · 3 bullish · 4 bearish · 4 neutral- BULLISH SC 13D/AOct 1, 2026
Advent International filed Amendment No. 1 to its Schedule 13D, disclosing entry into a…
The NDA formalizes Advent's access to non-public information, indicating the Special Committee is engaging in earnest. The standstill prevents Advent from launching a hostile bid or increasing its…
- BULLISH 8-KSep 9, 2026
Major TRA holders (Advent International, Spectrum Equity, 22C Capital, and founder Jason Krantz)…
This filing is the strongest signal yet that DH is in play. The TRA waiver removes a key economic obstacle that could have chilled or reduced consideration in a sale. Traders should watch for press…
- BULLISH 8-KSep 2, 2026
Definitive Healthcare Corp. (DH) disclosed that its Special Committee received a non-binding…
The stock is likely to trade toward the $1.02 offer price as the market prices in deal probability. Monitor for further announcements from the Special Committee, potential competing bids, or a…
- BULLISH PRESS RELEASESep 2, 2026
Definitive Healthcare's Special Committee announced receipt of a non-binding indication of…
Monitor for further announcements from the Special Committee regarding the proposal's evaluation, potential competing bids, or a definitive agreement. The stock is likely to trade near the $1.02…
All DH filing & press-release reports (12)
- SC 13D/A reportOct 1, 2026
- 8-K reportSep 9, 2026
- PRESS-RELEASE reportSep 2, 2026
- 8-K reportSep 2, 2026
- 8-K reportSep 2, 2026
- INST-CLUSTER reportAug 15, 2026
- 8-K reportAug 10, 2026
- PRESS-RELEASE reportAug 10, 2026
- 8-K reportJun 24, 2026
- DEFA14A reportApr 23, 2026
- PRESS-RELEASE reportApr 23, 2026
- 8-K reportApr 3, 2026